Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Regeneron Pharmaceuticals Inc., 3 years.
Regeneron Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −3 | $1,041.35 | $3,124 |
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −1 | $1,042.31 | $1,042 |
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −5 | $1,043.39 | $5,217 |
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −9 | $1,044.62 | $9,402 |
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −7 | $1,045.27 | $7,317 |
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −9 | $1,046.53 | $9,419 |
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −12 | $1,047.44 | $12,569 |
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −12 | $1,048.54 | $12,582 |
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −9 | $1,049.68 | $9,447 |
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −6 | $1,050.60 | $6,304 |
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −9 | $1,051.51 | $9,464 |
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −4 | $1,052.44 | $4,210 |
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −4 | $1,053.45 | $4,214 |
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −3 | $1,054.90 | $3,165 |
| Oct 1, 2024 | Regeneron Pharmaceuticals Inc. | Open-market sale | −3 | $1,056.68 | $3,170 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.